Isoleucine
Research stageAlso known as (2S,3S)-2-Amino-3-methylpentanoic acid, 2-Amino-3-methylvaleric acid, Aminosyn 10%, Sulfite-Free, Aminosyn 3.5 % M, Sulfite Free+42 more
(2S,3S)-2-Amino-3-methylpentanoic acid, 2-Amino-3-methylvaleric acid, Aminosyn 10%, Sulfite-Free, Aminosyn 3.5 % M, Sulfite Free, Aminosyn 8.5 % with Electrolytes, Sulfite-Free, Aminosyn 8.5%, Sulfite-Free, Aminosyn II 10 %, Aminosyn II 15%, Aminosyn II 8.5 % with Electrolytes, Sulfite-Free, Aminosyn II 8.5 %, Sulfite-Free, Aminosyn-HBC 7 %, Sulfite-Free, Aminosyn-PF 10 %, Sulfite-Free, Aminosyn-PF 7%, Branchamin, Clinisol 15, Freamine III 10, Hepatamine 8, Hepatasol, Ile, Ile - Isoleucine, L-Isoleucine, Nephramine, Plenamine, PremaSol, ProSol, ProcalAmine 3, Travasol 10, Travasol 10%, Trophamine, Trophamine 10 %, Trophamine 6 %, alpha-amino-beta-methylvaleric acid, Isoleucina, Clinimix 4.25/10, Clinimix 4.25/25, Clinimix 4.25/5, Clinimix 5/15, Clinimix 5/20, Clinimix 5/25, Clinimix E 2.75/5, Clinimix E 4.25/10, Clinimix E 4.25/5, Clinimix E 5/15, Clinimix E 5/20, Clinimix E 5/25, Isoleucinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- Cell research1
- Chang S1
- Chu X1
- Ding J1
- Du C1
- Feng T1
- Ge C1
- Geng M1
- Gong Y1
- Institutional Technology Service Center1
- Shanghai Mental Health Center1
- State Key Laboratory of Drug Research1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Isoleucine in the shared literature.
Studied across 3 of the same disease areas as Isoleucine in the shared literature.
Studied across 3 of the same disease areas as Isoleucine in the shared literature.
Studied across 3 of the same disease areas as Isoleucine in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature